Our Entrepreneurs

Leonardo Olivera

Laboratorios Clausen

Leonardo Olivera Leonardo Olivera

Impact metric

307% growth in jobs since selection
“I saw an opportunity to advance cancer research in Uruguay.
Country
Uruguay
Industry
Health Care/Life Sciences
Employees
137
partner
Gabriel Fernández
Website

Company Snapshot

Laboratorios Clausen is the first and only Uruguayan biotech firm to develop an entirely new molecule. Thrombopoetin, a human protein that stimulates the production of platelets, was patented in 1998. Today it is used in treatments for cancer and blood coagulation disorders. To elevate Laboratorios Clausen to the next level, Gabriel and Leonardo have constructed a state-of-the-art production facility that is one of only three EMEA Certified facilities in Latin America. Clausen was the subject of a Universidad ORT Uruguay case study.

Since selection by Endeavor, company revenues have grown by 256%.

Endeavor and LEONARDO OLIVERA

Leonardo and Gabriel have benefited from local strategic mentorship, support in strengthening their patent applications, custom workshops on management issues, and introductions to local business leaders to help foster the country’s biotech industry. They also benefited from the Ernst & Young Fellows program, and the eMBA program which developed a business plan for new patents and methods of seeking capital.

The Entrepreneurs have demonstrated commitment by participating as speakers at Endeavor events, and screening candidates.

From the Entrepreneurship Blog

Events

Greece's Kerstin Trikalitis, Co-Founder of Out There Media, Joins Jury at the 2014 Cannes Lions Festival

July 10th, 2014 — by admin

Endeavor Entrepreneur Kerstin Trikalitis, co-founder of Greece's Out There Media, was recently named to the jury in the "Mobile" category at the 2014 Cannes Lions Festival, a premiere international aw…

Read more

In the news

Argentina’s Globant Raises $59 Million on NYSE; Second-Ever U.S. IPO for an Endeavor Company

July 21st, 2014 — by admin

Argentina’s Globant, founded by Endeavor Entrepreneurs Martin Migoya, Guibert Englebienne, Néstor Nocetti and Martin Umaran, had its U.S. IPO on July 18th, raising nearly $59 million. The Buenos A…

Read more

Contact us

Press center

Community

Newsletter Sign Up